NCM Boston
NCM Boston
A
:quality(80))
Andreas CzechBioNTech, Germany
:quality(80))
Alex KneubehlBaylor College of Medicine, USA
:quality(80))
Anne-Sophie LebreCHU Reims, France
:quality(80))
Ailsa MacCalmanUniversity of Exeter, UK
:quality(80))
Anastasia McKinlayIndiana University & HHMI, USA
:quality(80))
Amit MathurSanofi, USA
:quality(80))
Ana PeresThe University of North Carolina at Chapel Hill, USA
:quality(80))
Aaron VinyColumbia University Irving Medical Center, USA
:quality(80))
Akelia Wauchope-OdumboAssociate Director, Technical Applications — Americas, Oxford Nanopore Technologies
B
:quality(80))
Bronya BoydonMachine Learning Bioinformatician, Oxford Nanopore Technologies
:quality(80))
Bradley HallAsuragen, USA
:quality(80))
Bryan LelandBioinformatics Manager, Commercial Applications, Oxford Nanopore Technologies
:quality(80))
Benjamin C. ReinerUniversity of Pennsylvania, USA
:quality(80))
Brynja SigurpálsdóttirdeCODE genetics, Iceland
C
:quality(80))
Cory BernhardsDEVCOM Chemical Biological Center, USA
:quality(80))
Chris BrownVP Strategic Programmes, Oxford Nanopore Technologies
:quality(80))
Colette CôtéPathoQuest, USA
:quality(80))
Christian GallardoSeattle Children's Research Institute, USA
:quality(80))
Carol GreiderUniversity of California, Santa Cruz, USA
:quality(80))
Chun-Chieh LinDartmouth Health, USA
:quality(80))
Chad PollardWasatch BioLabs, USA
:quality(80))
Charles A. SwoffordMIT Center for Biomedical Innovation, USA
:quality(80))
Carly TyerApplications Scientist, Oxford Nanopore Technologies
:quality(80))
Carika WeldonCariGenetics, Bermuda
D
:quality(80))
Daniel K. FabianLonza, UK
:quality(80))
Dan FordhamDirector, Strategic Product Management EMEA, Oxford Nanopore Technologies
:quality(80))
Daniel KimUniversity of California, Santa Cruz, USA
:quality(80))
Dmitrijs RotsErasmus MC, Netherlands
:quality(80))
David VanHouteRegeneron Pharmaceuticals, USA
:quality(80))
David YarmoshATCC, USA
:quality(80))
:quality(80))
G
:quality(80))
Gabriela PozoUniversity of San Francisco de Quito, Ecuador
:quality(80))
Gordon SangheraCEO, Oxford Nanopore Technologies
:quality(80))
Gaston VondenhoffLonza, The Netherlands
H
:quality(80))
Heather CarletonCenters for Disease Control & Prevention, USA
:quality(80))
Helen GunterThe BASE Facility, The University of Queensland, Australia
J
:quality(80))
Jessica AndersonSenior Field Applications Scientist, Oxford Nanopore Technologies
:quality(80))
Justin BeckerDana-Farber Cancer Institute & Massachusetts General Hospital, USA
:quality(80))
Jade BartoloAssociate Director, Automation, Oxford Nanopore Technologies
:quality(80))
Jack ColicchioSound Agriculture, USA
:quality(80))
Julie CollensVP, Commercial Operations AMR, Oxford Nanopore Technologies
:quality(80))
Jimmy CreithField Applications Scientist, Bioinformatics, Oxford Nanopore Technologies
:quality(80))
J. (Gus) GustafsonUniversity of Washington, USA
:quality(80))
Julie HaendigesU.S. Food and Drug Administration, USA
K
:quality(80))
Karine ChoquetUniversity of Sherbrooke, Canada
:quality(80))
Keith ConnollyModalis Therapeutics, USA
:quality(80))
Kamil KhanipovThe University of Texas Medical Branch, USA
:quality(80))
Katherine LawrenceMachine Learning and Bioinformatics Manager, Oxford Nanopore Technologies
L
:quality(80))
Lucia DaxingerLeiden University Medical Center, Netherlands
:quality(80))
Lantana GrubVanderbilt University, USA
:quality(80))
Lakmal JayasingheSenior VP, R&D Biologics, Oxford Nanopore Technologies
:quality(80))
Laura KamenetzkyCONICET, Argentina
:quality(80))
Logan MulroneyEMBL-EBI, UK & IIT, Italy
M
:quality(80))
Matthew BainbridgeRady Children's Institute for Genomic Medicine, USA
:quality(80))
Michael DeanNational Cancer Institute, USA
:quality(80))
Mathilde FilserCurie Institute, France
:quality(80))
Megan L. NoonanWashington University School of Medicine in St. Louis, USA
:quality(80))
Matt ParkerDirector, Clinical Bioinformatics Software, Oxford Nanopore Technologies
:quality(80))
Mile SikicGenome Institute of Singapore, A*STAR, Singapore
:quality(80))
Mike VellaSenior Director, Machine Learning, Oxford Nanopore Technologies
:quality(80))
:quality(80))
P
:quality(80))
Philipp ReschenederSenior Director, Applications Bioinformatics, Oxford Nanopore Technologies
:quality(80))
Paula SaffieClinica Santa María, Chile
:quality(80))
R
:quality(80))
Ranjith AnandeGenesis, USA
:quality(80))
Rachel O’NeillUniversity of Connecticut, USA
:quality(80))
Rachel RubinsteinTechnical Product Manager, Software, Oxford Nanopore Technologies
:quality(80))
Rosemary Sinclair DokosSenior VP, Product and Programme Management, Oxford Nanopore Technologies
:quality(80))
Radhakrishna TirumalaiMerck & Co., USA
:quality(80))
Rhydian WindsorResearch Scientist, Machine Learning, Oxford Nanopore Technologies
S
:quality(80))
Stacy L. SpringsMIT Center for Biomedical Innovation, USA
:quality(80))
Stephanie AbernathyVice President, Sales, Americas, Oxford Nanopore Technologies
:quality(80))
Stephanie ChrysanthouMemorial Sloan Kettering Cancer Center, USA
:quality(80))
Scott HickeyDirector, Commercial Applications, Oxford Nanopore Technologies
:quality(80))
Shilpa KobrenHarvard Medical School, USA
:quality(80))
Serge MonpoehoRegeneron Pharmaceuticals, USA
:quality(80))
Svetlana MadjunkovaCReATe Fertility Centre, Canada
:quality(80))
Sean McKenzieAssociate Director, Genomic Applications Bioinformatics, Oxford Nanopore Technologies
:quality(80))
Samuel ShelburneThe University of Texas MD Anderson Cancer Center, USA
:quality(80))
Sebastian B. TeitzveryTeitz Consulting, Germany
T
:quality(80))
Thomas GarciaBaylor College of Medicine, USA
:quality(80))
Tasos GogakosArena BioWorks & Massachusetts General Hospital, USA
:quality(80))
Tim WalkerApplied Industrial Support Specialist, Oxford Nanopore Technologies
:quality(80))
:quality(80))
:quality(80))
Oxford Nanopore Technologies
David VanHoute
:quality(80))
- Job title
- Institution
- Regeneron Pharmaceuticals, USA
- Biography
David has been with Regeneron Pharmaceuticals in QC virology since 2015. As the principal scientist he spearheaded the development of NGS-based assays for adventitious agent GMP testing. Currently, he leads a team of eight researchers continuing to modernize QC virology testing using NGS in the GMP space.
